Why the study?
What is the optimal pharmacological management for patients presenting with hypertensive crises?
What is the optimal pharmacological management for patients presenting with hypertensive crises?
This review outlines the management of hypertensive crises, emphasizing the use of newer titratable IV agents like clevidipine for emergencies and advising against older, more toxic agents.
No takes yet. Share an insight, caveat, or question.
Supports caution with select IV agents in hypertensive emergencies; leaves open optimal choices pending randomized data.
Joseph Varón (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: